Asset Details
Do you wish to reserve the book?
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
Do you wish to request the book?
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
2008
Overview
Although anticapsular antibodies confer serotype-specific immunity to pneumococci, children increase their ability to clear colonization before these antibodies appear, suggesting involvement of other mechanisms. We previously reported that intranasal immunization of mice with pneumococci confers CD4+ T cell-dependent, antibody- and serotype-independent protection against colonization. Here we show that this immunity, rather than preventing initiation of carriage, accelerates clearance over several days, accompanied by neutrophilic infiltration of the nasopharyngeal mucosa. Adoptive transfer of immune CD4+ T cells was sufficient to confer immunity to naïve RAG1(-/-) mice. A critical role of interleukin (IL)-17A was demonstrated: mice lacking interferon-gamma or IL-4 were protected, but not mice lacking IL-17A receptor or mice with neutrophil depletion. In vitro expression of IL-17A in response to pneumococci was assayed: lymphoid tissue from vaccinated mice expressed significantly more IL-17A than controls, and IL-17A expression from peripheral blood samples from immunized mice predicted protection in vivo. IL-17A was elicited by pneumococcal stimulation of tonsillar cells of children or adult blood but not cord blood. IL-17A increased pneumococcal killing by human neutrophils both in the absence and in the presence of antibodies and complement. We conclude that IL-17A mediates pneumococcal immunity in mice and probably in humans; its elicitation in vitro could help in the development of candidate pneumococcal vaccines.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Adult
/ Animals
/ CD4-Positive T-Lymphocytes - immunology
/ CD4-Positive T-Lymphocytes - transplantation
/ Child
/ Disease
/ Female
/ Humans
/ Immunity
/ Infectious Diseases/Bacterial Infections
/ Medicinska och farmaceutiska grundvetenskaper
/ Mice
/ Pneumococcal Infections - immunology
/ Streptococcus pneumoniae - immunology
/ Vaccines
